The final panel at this year’s Anglonordic Life Science Conference was led by Mike Ward, Global Head of Life Sciences & Healthcare Thought Leadership at Clarivate, who asked life science leaders for their wisdom on the subject: “If I knew then, what I know now.” The expert panel had a wealth of experience to draw […]
Each year, In Vivo spotlights the next wave of entrepreneurs and innovators making a difference in the biopharma, medtech and health technology sectors. The 30 Rising Leaders have been recognised for their achievements, talent, creativity and leadership and this year include four of Optimum’s fantastic clients. Firstly, Anthony DeBoer, VP of Business Development at Synaffix, […]
The first panel of the day, chaired by Mary Clark, our co-founder and CEO, saw a group of Europe’s leading investors – Hakan Goker, M Ventures; Maina Bhaman, Sofinnova Partners; Christian Elling, Lundbeckfonden; and Roel Bulthuis, Syncona – share sage advice for companies looking to raise funds, providing insights on the most important factors shaping […]
Emerging new Company veriNOS pharmaceuticals, established in October 2022, Led by CEO, Christian Wandersee and CMO Professor John Stover, provides an update on its revival of late-stage drug candidate ronopterin for the treatment of Traumatic Brain Injury (TBI). Ronopterin is the first and only iNOS inhibitor which has demonstrated repeated signs of neuroprotection in TBI […]
Strong potential for POLB 001 to be a blockbuster treatment for severe influenza Key Highlights · POLB 001 resulted in a highly significant reduction in p38 MAP kinase driven cytokines · POLB 001 treatment exhibited a marked reduction in multiple markers of systemic and local inflammation compared with placebo · Trial results demonstrate expected utility in severe influenza […]
